Bruna Rodrigues de Sousa, Camylla Carvalho de Melo, Manoel Marques Evangelista Oliveira, Sylvia Maria de Lemos Hinrichsen, Rossana de Aguiar Cordeiro, Reginaldo Gonçalves de Lima-Neto
{"title":"Isavuconazole对巴西假丝酵母菌（C. auris）的活性：EUCAST与CLSI的MIC比较。","authors":"Bruna Rodrigues de Sousa, Camylla Carvalho de Melo, Manoel Marques Evangelista Oliveira, Sylvia Maria de Lemos Hinrichsen, Rossana de Aguiar Cordeiro, Reginaldo Gonçalves de Lima-Neto","doi":"10.1080/17460913.2025.2544485","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>We evaluated the <i>in vitro</i> activity of isavuconazole against different <i>Candida</i> clinical species from Brazil, with an emphasis on <i>C. auris</i>, using CLSI and EUCAST, and compared the results to expand the literature on this new triazole.</p><p><strong>Methods: </strong>A total of 102 strains of <i>Candida</i> spp. were isolated from critically ill patients admitted to tertiary hospitals in Recife, Pernambuco, Brazil. All isolates were identified using MALDI-TOF MS and tested using broth microdilutions.</p><p><strong>Results: </strong>The species identified were <i>C. auris</i> (62), <i>C. albicans</i> (14), <i>C. tropicalis</i> (9), <i>C. parapsilosis</i> (5), <i>C. glabrata</i> (3), <i>C. metapsilosis</i>, <i>C. orthopsilosis</i> (2) each, <i>C. duobushaemulonii</i>, <i>Meyerozyma guilliermondii</i>, <i>Clavispora lusitaniae</i>, <i>C. nivariensis</i>, and <i>Wickerhamomyces anomolus</i> (1). A modal MIC<sub>90</sub> of ≤0.008 µg/mL and a wild-type modal upper limit value of <0.03 µg/mL were found. Thus, 99.1% (CLSI) and 95.1% (EUCAST) of the strains were wild-type. The overall essential agreement rate between the methods was 95.1% (±2 log<sup>2</sup> dilutions) and 89.2% (±1 log<sup>2</sup> dilution).</p><p><strong>Conclusion: </strong>Both methodologies were useful for evaluating the antifungal potential of isavuconazole and highlighted the low MICs of this triazole against the Brazilian collection of <i>Candida</i> spp., especially the emerging yeast <i>C. auris</i>.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"1-7"},"PeriodicalIF":2.4000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Isavuconazole activity against <i>Candida</i> species from Brazil focusing on <i>C. auris</i>: MIC comparison between EUCAST and CLSI.\",\"authors\":\"Bruna Rodrigues de Sousa, Camylla Carvalho de Melo, Manoel Marques Evangelista Oliveira, Sylvia Maria de Lemos Hinrichsen, Rossana de Aguiar Cordeiro, Reginaldo Gonçalves de Lima-Neto\",\"doi\":\"10.1080/17460913.2025.2544485\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>We evaluated the <i>in vitro</i> activity of isavuconazole against different <i>Candida</i> clinical species from Brazil, with an emphasis on <i>C. auris</i>, using CLSI and EUCAST, and compared the results to expand the literature on this new triazole.</p><p><strong>Methods: </strong>A total of 102 strains of <i>Candida</i> spp. were isolated from critically ill patients admitted to tertiary hospitals in Recife, Pernambuco, Brazil. All isolates were identified using MALDI-TOF MS and tested using broth microdilutions.</p><p><strong>Results: </strong>The species identified were <i>C. auris</i> (62), <i>C. albicans</i> (14), <i>C. tropicalis</i> (9), <i>C. parapsilosis</i> (5), <i>C. glabrata</i> (3), <i>C. metapsilosis</i>, <i>C. orthopsilosis</i> (2) each, <i>C. duobushaemulonii</i>, <i>Meyerozyma guilliermondii</i>, <i>Clavispora lusitaniae</i>, <i>C. nivariensis</i>, and <i>Wickerhamomyces anomolus</i> (1). A modal MIC<sub>90</sub> of ≤0.008 µg/mL and a wild-type modal upper limit value of <0.03 µg/mL were found. Thus, 99.1% (CLSI) and 95.1% (EUCAST) of the strains were wild-type. The overall essential agreement rate between the methods was 95.1% (±2 log<sup>2</sup> dilutions) and 89.2% (±1 log<sup>2</sup> dilution).</p><p><strong>Conclusion: </strong>Both methodologies were useful for evaluating the antifungal potential of isavuconazole and highlighted the low MICs of this triazole against the Brazilian collection of <i>Candida</i> spp., especially the emerging yeast <i>C. auris</i>.</p>\",\"PeriodicalId\":12773,\"journal\":{\"name\":\"Future microbiology\",\"volume\":\" \",\"pages\":\"1-7\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future microbiology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1080/17460913.2025.2544485\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/17460913.2025.2544485","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
Isavuconazole activity against Candida species from Brazil focusing on C. auris: MIC comparison between EUCAST and CLSI.
Aim: We evaluated the in vitro activity of isavuconazole against different Candida clinical species from Brazil, with an emphasis on C. auris, using CLSI and EUCAST, and compared the results to expand the literature on this new triazole.
Methods: A total of 102 strains of Candida spp. were isolated from critically ill patients admitted to tertiary hospitals in Recife, Pernambuco, Brazil. All isolates were identified using MALDI-TOF MS and tested using broth microdilutions.
Results: The species identified were C. auris (62), C. albicans (14), C. tropicalis (9), C. parapsilosis (5), C. glabrata (3), C. metapsilosis, C. orthopsilosis (2) each, C. duobushaemulonii, Meyerozyma guilliermondii, Clavispora lusitaniae, C. nivariensis, and Wickerhamomyces anomolus (1). A modal MIC90 of ≤0.008 µg/mL and a wild-type modal upper limit value of <0.03 µg/mL were found. Thus, 99.1% (CLSI) and 95.1% (EUCAST) of the strains were wild-type. The overall essential agreement rate between the methods was 95.1% (±2 log2 dilutions) and 89.2% (±1 log2 dilution).
Conclusion: Both methodologies were useful for evaluating the antifungal potential of isavuconazole and highlighted the low MICs of this triazole against the Brazilian collection of Candida spp., especially the emerging yeast C. auris.
期刊介绍：
Future Microbiology delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this increasingly important and vast area of research.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
